These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11730829)

  • 1. Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study.
    McNeely MJ; Edwards KL; Marcovina SM; Brunzell JD; Motulsky AG; Austin MA
    Atherosclerosis; 2001 Dec; 159(2):471-81. PubMed ID: 11730829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemia.
    Pei WD; Sun YH; Liu Q; Zheng WY; Zhang J; Zhang CY; Gong J; Hopkins PN; Hui RT; Liu LS; Yang YJ
    Int J Cardiol; 2007 Feb; 115(3):293-6. PubMed ID: 16797745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.
    Dallinga-Thie GM; Bu XD; van Linde-Sibenius Trip M; Rotter JI; Lusis AJ; de Bruin TW
    J Lipid Res; 1996 Jan; 37(1):136-47. PubMed ID: 8820109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism influences lipid phenotypes in Chinese families with familial combined hyperlipidemia.
    Pei WD; Zhang YH; Sun YH; Gu YC; Wang YF; Zhang CY; Zhang J; Liu LS; Hui RT; Liu YQ; Yang YJ
    Circ J; 2006 Dec; 70(12):1606-10. PubMed ID: 17127808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variation in the apolipoprotein C-III gene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Humphries S; Turner PR; Masana L
    J Lipid Res; 1997 Jun; 38(6):1061-9. PubMed ID: 9215535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial combined hyperlipidemia (FCHL) in children: the significance of early development of hyperapoB lipoproteinemia, obesity and aging.
    Kuromori Y; Okada T; Iwata F; Hara M; Noto N; Harada K
    J Atheroscler Thromb; 2002; 9(6):314-20. PubMed ID: 12560593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia.
    Schonfeld G; Aguilar-Salina C; Elias N
    Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia.
    Rauh G; Schuster H; Müller B; Schewe S; Keller C; Wolfram G; Zöllner N
    Atherosclerosis; 1990 Jul; 83(1):81-7. PubMed ID: 1975179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
    Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
    Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
    Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
    Cortner JA; Coates PM; Liacouras CA; Jarvik GP
    J Pediatr; 1993 Aug; 123(2):177-84. PubMed ID: 8345411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
    Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of insulin resistance in familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against alterations in Lecithin:cholesterol acyltransferase (LCAT) activity in familial combined hyperlipidemia.
    Ribalta J; La Ville AE; Vallvé JC; Girona J; Masana L
    Atherosclerosis; 1998 Jun; 138(2):383-9. PubMed ID: 9690923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
    Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.